7092 Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 

FEDERAL RESERVE SYSTEM 

Formations of, Acquisitions by, and 

Mergers of Bank Holding Companies 

The companies listed in this notice 

have applied to the Board for approval, 

pursuant to the Bank Holding Company 

Act of 1956 (12 U.S.C. 1841 et seq.) 

(BHC Act), Regulation Y (12 CFR part 

225), and all other applicable statutes 

and regulations to become a bank 

holding company and/or to acquire the 

assets or the ownership of, control of, or 

the power to vote shares of a bank or 

bank holding company and all of the 

banks and nonbanking companies 

owned by the bank holding company, 

including the companies listed below. 

The public portions of the 

applications listed below, as well as 

other related filings required by the 

Board, if any, are available for 

immediate inspection at the Federal 

Reserve Bank(s) indicated below and at 

the offices of the Board of Governors. 

This information may also be obtained 

on an expedited basis, upon request, by 

contacting the appropriate Federal 

Reserve Bank and from the Board’s 

Freedom of Information Office at 

https://www.federalreserve.gov/foia/ 

request.htm. Interested persons may 

express their views in writing on the 

standards enumerated in the BHC Act 

(12 U.S.C. 1842(c)). 

Comments regarding each of these 

applications must be received at the 

Reserve Bank indicated or the offices of 

the Board of Governors, Ann E. 

Misback, Secretary of the Board, 20th 

Street and Constitution Avenue NW, 

Washington DC 20551–0001, not later 

than February 25, 2021. 

A. Federal Reserve Bank of San 

Francisco (Sebastian Astrada, Director, 

Applications) 101 Market Street, San 

Francisco, California 94105–1579: 1. St. 

Laurent Investments LLC, Vancouver, 

Washington; to become a bank holding 

company by acquiring People’s Bank of 

Commerce, Medford, Oregon. 

Board of Governors of the Federal Reserve 

System, January 21, 2021. 

Michele Taylor Fennell, 

Deputy Associate Secretary of the Board. 

[FR Doc. 2021–01690 Filed 1–25–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–21–0728] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled National 

Notifiable Diseases Surveillance System 

(NNDSS) to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on October 

23, 2020 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

National Notifiable Diseases 

Surveillance System (NNDSS) (0920– 

0728, Exp. 4/30/23)—Revision—Center 

for Surveillance, Epidemiology and 

Laboratory Services (CSELS), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

The Public Health Services Act (42 

U.S.C. 241) authorizes CDC to 

disseminate nationally notifiable 

condition information. The National 

Notifiable Diseases Surveillance System 

(NNDSS) is based on data collected at 

the state, territorial and local levels as 

a result of legislation and regulations in 

those jurisdictions that require health 

care providers, medical laboratories, 

and other entities to submit healthrelated data on reportable conditions to 

public health departments. These 

reportable conditions, which include 

infectious and non-infectious diseases, 

vary by jurisdiction depending upon 

each jurisdiction’s health priorities and 

needs. Each year, the Council of State 

and Territorial Epidemiologists (CSTE), 

supported by CDC, determines which 

reportable conditions should be 

designated nationally notifiable or 

under standardized surveillance. 

CDC requests a three-year approval for 

a Revision for the NNDSS, (OMB 

Control No. 0920–0728, Expiration Date 

04/30/2023). This Revision includes 

requests for approval to: (1) Receive case 

notification data for Multisystem 

Inflammatory Syndrome (MIS) 

associated with Coronavirus Disease 

2019 (COVID–19); (2) receive new 

disease-specific data elements for 

Anthrax, Brucellosis, 

Campylobacteriosis, Cholera, 

Cryptosporidiosis, Hansen’s Disease, 

Leptospirosis, Melioidosis, MIS 

associated with COVID–19, COVID–19, 

S. Paratyphi Infection, S. Typhi 

Infection, Salmonellosis, STEC, 

Shigellosis, and Vibriosis; and (3) 

Receive new vaccine-related data 

elements for all conditions. 

The NNDSS currently facilitates the 

submission and aggregation of case 

notification data voluntarily submitted 

to CDC from 60 jurisdictions: Public 

health departments in every U.S. state, 

New York City, Washington DC, five 

Federal Register / Vol. 86, No. 15 / Tuesday, January 26, 2021 / Notices 7093 

U.S. territories (American Samoa, the 

Commonwealth of Northern Mariana 

Islands, Guam, Puerto Rico, and the U.S. 

Virgin Islands), and three freely 

associated states (Federated States of 

Micronesia, the Republic of the 

Marshall Islands, and the Republic of 

Palau). This information is shared 

across jurisdictional boundaries and 

both surveillance and prevention and 

control activities are coordinated at 

regional and national levels. 

Approximately 90% of case 

notifications are encrypted and 

submitted to NNDSS electronically from 

already existing databases by automated 

electronic messages. When automated 

transmission is not possible, case 

notifications are faxed, emailed, 

uploaded to a secure network or entered 

into a secure website. All case 

notifications that are faxed or emailed 

are done so in the form of an aggregate 

weekly or annual report, not individual 

cases. These different mechanisms used 

to send case notifications to CDC vary 

by the jurisdiction and the disease or 

condition. Jurisdictions remove most 

personally identifiable information (PII) 

before data are submitted to CDC, but 

some data elements (e.g., date of birth, 

date of diagnosis, county of residence) 

could potentially be combined with 

other information to identify 

individuals. Private information is not 

disclosed unless otherwise compelled 

by law. All data are treated in a secure 

manner consistent with the technical, 

administrative, and operational controls 

required by the Federal Information 

Security Management Act of 2002 

(FISMA) and the 2010 National Institute 

of Standards and Technology (NIST) 

Recommended Security Controls for 

Federal Information Systems and 

Organizations. Weekly tables of 

nationally notifiable diseases are 

available through CDC WONDER and 

data.cdc.gov. Annual summaries of 

finalized nationally notifiable disease 

data are published on CDC WONDER 

and data.cdc.gov and disease-specific 

data are published by individual CDC 

programs. 

The burden estimates include the 

number of hours that the public health 

department uses to process and send 

case notification data from their 

jurisdiction to CDC. Specifically, the 

burden estimates include separate 

burden hours incurred for automated 

and non-automated transmissions, 

separate weekly burden hours incurred 

for modernizing surveillance systems as 

part of NNDSS Modernization Initiative 

(NMI) implementation, separate burden 

hours incurred for annual data 

reconciliation and submission, and 

separate one-time burden hours 

incurred for the addition of new 

diseases and data elements. The burden 

estimates for the one-time burden for 

reporting jurisdictions are for the 

addition of case notification data for 

MIS associated with COVID–19; diseasespecific data elements for Anthrax, 

Brucellosis, Campylobacteriosis, 

Cholera, Cryptosporidiosis, Hansen’s 

Disease, Leptospirosis, Melioidosis, MIS 

associated with COVID–19, COVID–19, 

S. Paratyphi Infection, S. Typhi 

Infection, Salmonellosis, STEC, 

Shigellosis, and Vibriosis; and vaccine 

data elements for all diseases. The 

estimated annual burden for the 257 

respondents is 18,954 hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

States .............................................................. Weekly (Automated) ....................................... 50 52 20/60 

States .............................................................. Weekly (Non-automated) ............................... 10 52 2 

States .............................................................. Weekly (NMI Implementation) ........................ 50 52 4 

States .............................................................. Annual ............................................................ 50 1 75 

States .............................................................. One-time Addition of Diseases and Data Elements.50 1 12 

Territories ........................................................ Weekly (Automated) ....................................... 5 52 20/60 

Territories ........................................................ Weekly, Quarterly (Non-automated) .............. 5 56 20/60 

Territories ........................................................ Weekly (NMI Implementation) ........................ 5 52 4 

Territories ........................................................ Annual ............................................................ 5 1 5 

Territories ........................................................ One-time Addition of Diseases and Data Elements.5 1 12 

Freely Associated States ................................ Weekly (Automated) ....................................... 3 52 20/60 

Freely Associated States ................................ Weekly, Quarterly (Non-automated) .............. 3 56 20/60 

Freely Associated States ................................ Annual ............................................................ 3 1 5

Freely Associated States ................................ One-time Addition of Diseases and Data Elements.3 1 12 

Cities ............................................................... Weekly (Automated) ....................................... 2 52 20/60 

Cities ............................................................... Weekly (Non-automated) ............................... 2 52 2 

Cities ............................................................... Weekly (NMI Implementation) ........................ 2 52 4 

Cities ............................................................... Annual ............................................................ 2 1 75 

Cities ............................................................... One-time Addition of Diseases and Data Elements.2 1 12 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–01619 Filed 1–25–21; 8:45 am] 

BILLING CODE 4163–18–P